Champions Oncology Q1 Revenue Up 9% to $15.2mln, Data Licensing Surges

Champions Oncology reported Q1 2027 revenue of $15.2 million, up 9% YoY, and a gross margin of 50%, up from 43% in Q1 fiscal '26. Data licensing revenue exceeded total fiscal 2026 data revenue at $893,000, while adjusted EBITDA was positive at $671,000, marking the fifth consecutive quarter of positive adjusted EBITDA. However, GAAP net loss was $426,000, and sales and marketing expense increased to $3 million from $1.8 million YoY. Cash used in operations was approximately $500,000, and the cash balance decreased to $4.4 million.